- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis.Bladder CancerJune 3, 2026
-
Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center.Bladder CancerJune 3, 2026
-
Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules.Bladder CancerJune 2, 2026
-
What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee.Bladder CancerJune 2, 2026
-
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.Bladder CancerJune 2, 2026
-
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy.Bladder CancerJune 1, 2026
-
Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus.Bladder CancerJune 1, 2026
-
Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer.Bladder CancerJune 1, 2026
-
Durvalumab and BCG Approved for Treating High-Risk NMIBCBladder CancerMay 29, 2026
-
Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort.Bladder CancerMay 29, 2026
Beyond the Abstracts
-
Detection of Bladder Cancer in Patients with Microscopic Hematuria Using Oncuria-Detect: Results of a Prospective, Multicenter International Study - Beyond the AbstractBladder CancerMay 26, 2026
-
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design - Beyond the AbstractBladder CancerMay 22, 2026
-
Impact of Pelvic Lymph Node Dissection on Oncological Outcomes in Patients with Clinically Staged Non-Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Systematic Review - Beyond the AbstractBladder CancerMay 22, 2026
-
Population-Based Outcomes of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer in Older Adults - Beyond the AbstractBladder CancerMay 21, 2026
-
Advances and Challenges of PET Imaging in Bladder Cancer-an Update and Future Trends - Beyond the AbstractBladder CancerMay 20, 2026
-
Real-World Effectiveness of Avelumab, Pembrolizumab, and Enfortumab Vedotin in Patients with Advanced Urothelial Carcinoma with Squamous Differentiation (ARON-2EV) - Beyond the AbstractBladder CancerMay 14, 2026
-
Preferred Treatment Sequencing for Metastatic Urothelial Carcinoma (mUC) in the Era of Perioperative and First-Line (1L) Checkpoint Inhibitor: Results From a National Survey of Genitourinary Oncologists - Beyond the AbstractBladder CancerMay 7, 2026
-
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine Cytology - Beyond the AbstractBladder CancerMay 6, 2026
-
Implications of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score as a Predictor of Neoadjuvant Chemotherapy Response in Bladder Cancer Patients - Beyond the AbstractBladder CancerApril 24, 2026
-
Pembrolizumab in Combination with Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial - Beyond the AbstractBladder CancerApril 20, 2026